Edition:
United States

Aspen Group Inc (ASPU.OQ)

ASPU.OQ on NASDAQ Stock Exchange Capital Market

8.66USD
15 Dec 2017
Change (% chg)

$-0.34 (-3.78%)
Prev Close
$9.00
Open
$8.95
Day's High
$8.98
Day's Low
$8.36
Volume
8,167
Avg. Vol
7,745
52-wk High
$9.25
52-wk Low
$5.35

Latest Key Developments (Source: Significant Developments)

Aspen Group Q2 loss per share $0.04
Wednesday, 13 Dec 2017 04:01pm EST 

Dec 13 (Reuters) - Aspen Group Inc ::ASPEN GROUP REPORTS RECORD REVENUE OF $4.85 MILLION IN Q2 FISCAL 2018.Q2 REVENUE $4.852 MILLION VERSUS I/B/E/S VIEW $4.9 MILLION.Q2 LOSS PER SHARE $0.04.Q2 EARNINGS PER SHARE VIEW $-0.02 -- THOMSON REUTERS I/B/E/S.  Full Article

Goudy Park Management reports 7.4 pct passive stake in Aspen Group as of Nov 8
Wednesday, 15 Nov 2017 05:20pm EST 

Nov 15 (Reuters) - Aspen Group Inc :Goudy Park Management reports 7.4 percent passive stake in Aspen Group Inc as of Nov 8- SEC Filing‍​.  Full Article

Aspen Group receives approval from WSCUC to buy United States University
Monday, 13 Nov 2017 08:00am EST 

Nov 13 (Reuters) - Aspen Group Inc ::Aspen Group receives approval from WSCUC to acquire United States University.Aspen - ‍upon deal close, Aspen to continue to operate United States University as independent, for-profit university governed by its board of trustees​.  Full Article

Aspen Group reports 54 pct revenue growth in Q1 fiscal 2018
Thursday, 14 Sep 2017 04:01pm EDT 

Sept 14 (Reuters) - Aspen Group Inc :Aspen Group reports 54% revenue growth in Q1 fiscal 2018.Q1 revenue rose 54 percent to $4.243 million.Aspen Group Inc - Qtrly ‍net loss applicable to shareholders of $767,079, as compared to qtrly net loss of $505,447 in prior fiscal year​.  Full Article

Astrazeneca says Aspen acquires remaining rights to AZ anaesthetics
Thursday, 14 Sep 2017 02:00am EDT 

Sept 14 (Reuters) - Astrazeneca Plc ::ASPEN ACQUIRES REMAINING RIGHTS TO AZ ANAESTHETICS.ENTERED AGREEMENT WITH ASPEN GLOBAL; AGI TO ACQUIRE RESIDUAL RIGHTS TO ESTABLISHED ANAESTHETIC MEDICINES.UUNDER NEW AGREEMENT, AGI WILL NO LONGER PAY ROYALTIES TO ASTRAZENECA​.AGI TO BUY REMAINING RIGHTS TO INTELLECTUAL PROPERTY; MANUFACTURING KNOW- HOW RELATED TO ANAESTHETIC MEDICINES FOR UPFRONT CONSIDERATION OF $555 MILLION.‍NEW, ADDITIONAL AGREEMENT IS EXPECTED TO CLOSE IN Q4 OF 2017, DOES NOT IMPACT ASTRAZENECA'S FINANCIAL GUIDANCE FOR 2017​.AGI TO PAY ASTRAZENECA UP TO $211 MLN IN PERFORMANCE-RELATED MILESTONES BASED ON SALES; GROSS MARGIN DURING PERIOD FROM 1 SEPT TO 30 NOV 2019.ASTRAZENECA WILL CONTINUE TO MANUFACTURE AND SUPPLY MEDICINES TO AGI DURING A TRANSITION PERIOD OF UP TO FIVE YEARS.  Full Article

Aspen Group Q4 revenue rose 72 percent to $2.671 million
Wednesday, 27 Jul 2016 04:17pm EDT 

Aspen Group Inc : Aspen Group reports record fourth quarter FY'2016 results, revenue accelerates to 72 pct growth yoy . Q4 revenue rose 72 percent to $2.671 million .Sees FY 2017 revenue up at least 50 percent.  Full Article

Aspen Group Q4 preliminary revenue $2.5 mln
Monday, 23 May 2016 08:01am EDT 

Aspen Group Inc :Aspen Group announces preliminary fourth quarter revenue of $2.5 million, delivering over 61% growth YoY and over 15% sequentially.  Full Article

BRIEF-Aspen Group Q2 loss per share $0.04

* ASPEN GROUP REPORTS RECORD REVENUE OF $4.85 MILLION IN Q2 FISCAL 2018